NL-OMON26629已完成不适用
A randomized multicenter study of carboplatin-gemcitabine versus carboplatin-paclitaxel in elderly patients with non-small cell lung cancer with emphasis on geriatric assessment and quality of life: <br>The NVALT-3 study.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- VALT
- 入组人数
- 182
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histologically or cytologically confirmed inoperable (stage III) or disseminated (stage IV) non small cell lung cancer;
- •2. No previous chemo- and or radiotherapy;
排除标准
- •1. Patients with a mixed form of NSCLC and SCLC;
- •2. Active uncontrolled infection;
研究者
相似试验
已完成
2 期
Vandetanib in non-cisplatin fit patients with urothelial cancersocally advanced and/or metastatic transitional cell carcinoma of the urotheliumMalignant neoplasm of other and unspecified urinary organsCancerISRCTN68146831Cardiff University (UK)82
已完成
不适用
Randomized phase II study of carboplatin / gemcitabine versus vinorelbine / gemcitabine in patients with advanced non-small cell lung cancerStage IIIb/IV NSCLCJPRN-C000000110West Japan Oncology Group120
已完成
2 期
Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLCNon-Small-Cell-Lung CancerNCT00463515University Hospital, Antwerp77
已完成
2 期
Comparison of Single-Agent Carboplatin Vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast CancerBreast CancerNCT02531932Amy Tiersten64
未知
不适用
Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancerJPRN-C000000112Kumamoto University School of Medicine55